Search Results - "SCHIELE, F"

Refine Results
  1. 1
  2. 2
  3. 3

    Effect of Paraoxonase-1 Polymorphism on Clinical Outcomes in Patients Treated With Clopidogrel After an Acute Myocardial Infarction by Simon, T, Steg, P G, Becquemont, L, Verstuyft, C, Kotti, S, Schiele, F, Ferrari, E, Drouet, E, Grollier, G, Danchin, N

    Published in Clinical pharmacology and therapeutics (01-10-2011)
    “…Paraoxonase–1 (PON1) Q192R polymorphism was recently suggested to determine per se clopidogrel response on major cardiovascular events (MACEs). We assessed the…”
    Get full text
    Journal Article
  4. 4

    Writing a scientific article: A step-by-step guide for beginners by Ecarnot, F, Seronde, M.-F, Chopard, R, Schiele, F, Meneveau, N

    Published in European geriatric medicine (01-12-2015)
    “…Abstract Many young researchers find it extremely difficult to write scientific articles, and few receive specific training in the art of presenting their…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project by Schiele, F., De Bacquer, D., Vincent-Viry, M., Beisiegel, U., Ehnholm, C., Evans, A., Kafatos, A., Martins, M.C., Sans, S., Sass, C., Visvikis, S., De Backer, G., Siest, G.

    Published in Atherosclerosis (01-10-2000)
    “…As part of the ApoEurope Project, the apolipoprotein E (apo E) serum concentration and polymorphism were determined in 6934 healthy subjects aged 25–64 years…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction by Schiele, F., Descotes-Genon, V., Seronde, M. F., Blonde, M. C., Legalery, P., Meneveau, N., Ecarnot, F., Mercier, M., Penfornis, A., Thebault, L., Boumal, D., Bassand, J-P.

    Published in Diabetic medicine (01-12-2006)
    “…Rationale and aim  In patients with an acute myocardial infarction, admission hyperglycaemia (AH) is a major risk factor for mortality. However, the predictive…”
    Get full text
    Journal Article
  10. 10

    Use of recombinant factor VIIa (NovoSeven(®)) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux by Luporsi, P, Chopard, R, Janin, S, Racadot, E, Bernard, Y, Ecarnot, F, Séronde, M F, Briand, F, Guignier, A, Descotes-Genon, V, Meneveau, N, Schiele, F

    Published in Acute cardiac care (01-06-2011)
    “…Fondaparinux has a favourable efficacy-safety profile but if major bleeding occurs, reversal of antithrombotic treatment is challenging. We present clinical…”
    Get more information
    Journal Article
  11. 11

    Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism : Immediate clinical and hemodynamic outcome and one-year follow-up by MENEVEAU, N, SCHIELE, F, BASSAND, J.-P, METZ, D, VALETTE, B, ATTALI, P, VUILLEMENOT, A, GROLLIER, G, ELAERTS, J, MOSSARD, J.-M, VIEL, J.-F

    “…This study sought to compare the efficacy of 2-h regimens of alteplase and streptokinase in acute massive pulmonary embolism. The primary end point was…”
    Get full text
    Conference Proceeding Journal Article
  12. 12
  13. 13
  14. 14

    Streptokinase vs alteplase in massive pulmonary embolism : A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction by MENEVEAU, N, SCHIELE, F, VUILLEMENOT, A, VALETTE, B, GROLLIER, G, BERNARD, Y, BASSAND, J.-P

    Published in European heart journal (01-07-1997)
    “…The aim of the study was to test the efficacy of recombinant tissue plasminogen activator and streptokinase in massive pulmonary embolism, the primary…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Need for revisiting the concept of reference values by Henny, J, Petitclerc, C, Fuentes-Arderiu, X, Petersen, P H, Queraltó, J M, Schiele, F, Siest, G

    Published in Clinical chemistry and laboratory medicine (01-07-2000)
    “…The reference values concept has been adopted by health care professionals, including clinical chemists, laboratory scientists, and clinicians and…”
    Get more information
    Journal Article
  17. 17

    Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia by Schiele, F, Vuillemenot, A, Kramarz, P, Kieffer, Y, Anguenot, T, Bernard, Y, Bassand, J P

    Published in American journal of hematology (01-09-1995)
    “…Heparin-induced thrombocytopenia is a rare but severe complication of heparin therapy that can result in severe venous or arterial thromboembolic events and…”
    Get more information
    Journal Article
  18. 18

    The “angioplastically correct” follow up strategy after stent implantation by SCHIELE, FRANÇOIS

    Published in Heart (British Cardiac Society) (01-04-2001)
    “…Currently, in routine practice as well as in clinical trials, there is more interest in the clinical outcome and the event free survival of the patient, (that…”
    Get full text
    Journal Article
  19. 19
  20. 20